CRANBURY, N.J., March 11 /PRNewswire-FirstCall/ -- Amicus Therapeutics today announced that the Company's President and Chief Executive Officer John F. Crowley will be presenting at the upcoming Cowen and Company 29th Annual Healthcare Conference. Mr. Crowley's presentation is scheduled to begin on Tuesday, March 17 at 9:30 a.m. Eastern Time.
Individuals can listen to a live webcast of the presentation by logging on to the Investors section of the Amicus Therapeutics' Web site, http://www.amicustherapeutics.com. Participants should allow approximately five to ten minutes prior to the presentation's start time to visit the site and download any streaming media software needed to listen to the Internet webcast. A replay of the webcast will also be available on the Company's Web site for 30 days.
About Amicus Therapeutics
Amicus Therapeutics is a biopharmaceutical company developing novel, oral therapeutics known as pharmacological chaperones for the treatment of a range of human genetic diseases. Pharmacological chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with unmet medical needs.
FOLD -G
CONTACT: Jenene Thomas of Amicus Therapeutics, +1-609-662-5084,
jthomas@amicustherapeutics.com; or Kate Weiss of Porter Novelli Life
Sciences, +1-617-897-8255, kweiss@pnlifesciences.com, for Amicus
Therapeutics
Web site: http://www.amicustherapeutics.com/
